Estes Lecture, May 13, 2013: “The FDA and the Remaking of Modern Clinical Research” with Daniel Carpenter, PhD

By , April 10, 2013
Share on FriendFeed
Post to Google Buzz
Bookmark this on Digg
Share on Facebook
Post to Twitter
Bookmark this on Google Bookmarks

Daniel P. Carpenter

Daniel P. Carpenter

The Boston Medical Library presents the J. Worth Estes, M.D., History of Medicine Lecture:

“The FDA and the Remaking of Modern Clinical Research”.

Daniel Carpenter, PhD

Allie S. Freed Professor of Government; Director of the Center for American Political Studies at Harvard University.
Monday, May 13, 2013
5:30 p.m.
Armenise Amphitheatre, HMS
200 Longwood Avenue, Boston

Please rsvp to Roz Vogel at:
617-432-4807 or email rvogel@hms.harvard.edu

A downloadable flyer is available here: estes lecture_5-13

Dr. Carpenter is the author of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton 2010) and received the 2011 Allan Sharlin Memorial Award from the Social Science History Association. In his lecture he will touch upon “how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. He explains how the FDA’s reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA’s waning influence in drug regulation today”.

Leave a Reply

Panorama Theme by Themocracy